The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Nucleic Acid Based Gene Therapy Market At The End Of The 2026–2030 Forecast Period?
The nucleic acid based gene therapy market size has seen rapid growth recently. It is forecast to increase from $0.88 billion in 2025 to $0.97 billion in 2026, at a compound annual growth rate (CAGR) of 10.2%. The historical period’s expansion can be linked to progress in molecular biology research, a deeper insight into genetic disease mechanisms, the broadening of clinical trials for gene therapies, rising funding in biotechnology research, and initial regulatory clearances for nucleic acid therapies.
The nucleic acid based gene therapy market is projected to experience swift expansion over the coming years. Its value is anticipated to reach $1.44 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.4%. This projected growth during the forecast period stems from factors such as the increasing embrace of crispr-based treatments, a surging need for therapies targeting rare diseases, the broadening of gene therapy manufacturing capabilities, an escalating emphasis on personalized oncology treatments, and a rise in both public and private investment for genetic medicine. Key trends anticipated during the forecast period encompass a greater acceptance of rna-based therapeutics, an increasing deployment of both viral and non-viral gene delivery mechanisms, a sharpened focus on targeted gene editing technologies, the broadening of personalized genetic treatment options, and a heightened importance placed on precision medicine applications.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2820&type=smp
Which Market Drivers Are Supporting The Expansion Of The Nucleic Acid Based Gene Therapy Market?
The future expansion of the nucleic acid based gene therapy market is anticipated to be driven by increasing financial backing from both governmental bodies and corporations. This financial assistance encompasses monetary investments, grants, or subsidies offered by public or private organizations to further the research, development, and commercialization of these therapies. The increase in financial aid stems from a growing global focus on developing treatments for rare and genetic conditions that currently lack definitive cures. Government funding specifically for nucleic-acid-based gene therapy expedites advancements by providing critical resources for research, clinical trials, and foundational infrastructure, directly fostering innovation and the creation of effective treatments. For example, in July 2023, the U.S. National Institutes of Health, a federal health research agency in the U.S., reported awarding more than $140 million to expedite genome editing methods, such as CRISPR and other nucleic acid technologies, targeting rare neurological and blood disorders. This represents a substantial rise from the $92 million in annual funding provided in 2022. Consequently, the expanding financial support from governments and companies is a key factor propelling the growth of the nucleic acid based gene therapy market.
What Segment Types Make Up The Nucleic Acid Based Gene Therapy Market?
The nucleic acid based gene therapy market covered in this report is segmented –
1) By Technology: Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies
2) By Application: Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases
3) By End User: Hospitals And Clinics, Academic And Research Institutes
Subsegments:
1) By Anti-Sense And Anti-Gene: Oligonucleotide Therapeutics, Peptide Nucleic Acids (PNA), Morpholino Oligomers (MO)
2) By Short Inhibitory Sequences (siRNA): Synthetic siRNA, Encapsulation/Delivery Systems for siRNA, Target-specific siRNA Therapies
3) By Gene Transfer Therapy: Viral Vectors (Adenovirus, Lentivirus, Retrovirus, AAV), Non-Viral Vectors (Liposomes, Electroporation, Gene Gun)
4) By Nucleoside Analogs: Purine Analogs, Pyrimidine Analogs
5) By Ribozymes: Trans-Splicing Ribozymes, Hammerhead Ribozymes
6) By Aptamers: RNA Aptamers, DNA Aptamers, Small Molecule Binding Aptamers
7) By Other Technologies: CRISPR-based Gene Editing, Zinc Finger Nucleases (ZFN), Transcription Activator-Like Effector Nucleases (TALENs)
Which Market Trends Are Creating New Opportunities In The Nucleic Acid Based Gene Therapy Market?
Prominent companies operating in the nucleic acid-based gene therapy market are directing their efforts towards personalized, autologous stem-cell therapies, including genetically modified hematopoietic stem-cell infusions, to manage rare inherited diseases. Autologous therapies describe treatments where a patient’s own stem cells are extracted, genetically rectified, and re-infused to restore the deficient biochemical function. As an illustration, in March 2024, Orchard Therapeutics, a US-based enterprise that supplies pharmaceuticals, announced the U.S. Food and Drug Administration approved Lenmeldy (atidarsagene autotemcel) for children afflicted with metachromatic leukodystrophy (MLD). Lenmeldy employs the patient’s own hematopoietic stem cells, which have been genetically altered to produce a functional ARSA gene, thereby facilitating enzyme restoration in the nervous system. This achievement in regulation demonstrates the capacity of companies to commercialize sophisticated, autologous gene therapies even with substantial manufacturing costs.
Who Are The Key Players Driving Competition In The Nucleic Acid Based Gene Therapy Market?
Major companies operating in the nucleic acid based gene therapy market are Celsion Corporation, Wave Life Sciences, Imugene Ltd., Caperna LLC, Phylogica Limited, Protagonist Therapeutics Inc., Benitec Biopharma Ltd., EGEN, BioMedica, Transgene SA, Copernicus Therapeutics Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., Beam Therapeutics Inc., BioNTech SE, Bluebird Bio Inc., CRISPR Therapeutics AG, Editas Medicine Inc., Genevant Sciences Inc., Homology Medicines Inc., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., MaxCyte Inc., Moderna Inc., Novartis International AG, Orchard Therapeutics plc, Precision BioSciences Inc., REGENXBIO Inc.
Read the full nucleic acid based gene therapy market report here:
How Is The Nucleic Acid Based Gene Therapy Market Distributed Across Key Geographic Regions?
North America was the largest region in the nucleic acid-based gene therapy market in 2025. Western Europe was the second-largest region in the nucleic acid-based gene therapy market report. The regions covered in the nucleic acid based gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Nucleic Acid Based Gene Therapy Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2820&type=smp
Browse Through More Reports Similar to the Global Nucleic Acid Based Gene Therapy Market 2026, By The Business Research Company
Genes Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Cell And Gene Therapy Clinical Trial Services Market Report 2026
Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model